AIS News Antares Pharma to Present at BMO Capital Markets Focus on Healthcare 2006 Investor Conference
EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (Amex:AIS) announced that Jack E. Stover, President
& Chief Executive Officer is scheduled to present at the BMO Focus on
Healthcare Conference on Wednesday, December 6, 2006 at 2:30 pm (ET) at
the Millennium Broadway Hotel in New York City. A live webcast of the
audio portion of this presentation will be available via http://www.bmocm.com/conferences/healthcare2006/default.aspx.
Antares Pharma
Antares Pharma is a specialized pharma product development company
focused on developing patented drug delivery systems and injectable
device engineering capabilities. Antares’
current technology platforms include its ATD™
Advanced Transdermal Delivery system, and its related TecTix™
system for topical and transmucosal delivery, its Easy Tec™
oral fast-melt technology, and subcutaneous injection technology
platforms including both Vibex™ disposable
mini-needle injection device and Valeo™/Vision®
reusable needle-free injection devices. Antares Pharma is committed to
leveraging its multiple drug delivery platforms to add value to existing
drugs and to create new pharmaceutical products and injectable devices.
Overall, Antares’ product pipeline, if
approved, will address unmet medical needs by reducing side effect
profiles, improving safety, increasing effectiveness, and improving
patient compliance and convenience. Antares Pharma has corporate
headquarters in Princeton Crossroads Corporate Center in Ewing, NJ, with
subsidiaries performing research, development, manufacturing and product
commercialization activities in Minneapolis, Minnesota and Basel,
Switzerland.
